KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $72.3 million.

  • West Pharmaceutical Services' Shares Outstanding (Weighted Average) fell 95.89% to $72.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $72.3 million, marking a year-over-year decrease of 95.89%. This contributed to the annual value of $72.3 million for FY2025, which is 95.89% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported Shares Outstanding (Weighted Average) of $72.3 million as of Q4 2025, which was down 95.89% from $72.3 million recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Shares Outstanding (Weighted Average) ranged from a high of $74.5 million in Q1 2023 and a low of $72.3 million during Q2 2025
  • In the last 5 years, West Pharmaceutical Services' Shares Outstanding (Weighted Average) had a median value of $74.0 million in 2021 and averaged $73.7 million.
  • In the last 5 years, West Pharmaceutical Services' Shares Outstanding (Weighted Average) surged by 67.66% in 2021 and then crashed by 174.97% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Shares Outstanding (Weighted Average) (Quarter) stood at $74.4 million in 2021, then changed by 0.0% to $74.4 million in 2022, then fell by 0.13% to $74.3 million in 2023, then decreased by 1.75% to $73.0 million in 2024, then dropped by 0.96% to $72.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $72.3 million in Q4 2025, compared to $72.3 million in Q3 2025 and $72.3 million in Q2 2025.